Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 212K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -681.26k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -17.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -45.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -76.00% |
| Recommedations | - | Quick Ratio | - | Shares Outstanding | 35.33M | 52W Low Chg | 50.00% |
| Insider Own | 17.99% | ROA | -9,537.98% | Shares Float | 29.21M | Beta | 0.40 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00600 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 3,532 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 27,710 | Change | 0.00% |
About GENETHERA INC
GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. It offers treatments for zoonotic diseases, such as COVID -19 disease; paratuberculosis (Johne's disease) that is in Stage III clinical phase; mad cow and chronic wasting diseases; and E.coli and salmonella infections, as well as develops vaccine for mycobacterium avium sub paratuberculosis bacteria. The company's Molecular Robotic/AI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. GeneThera, Inc. is based in Westminster, Colorado.